Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
14.05.25
/
50%
€3.56
Target price
14.05.26
€11.62
Performance (%)
65.31%
Price
24.04.26
€5.89
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals has seen massive gains of 65.31%. This prediction currently runs until 14.05.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | -4.696% | -4.696% |
| iShares Core DAX® | -1.741% | 5.979% |
| iShares Nasdaq 100 | 2.815% | 11.827% |
| iShares Nikkei 225® | -0.109% | 11.692% |
| iShares S&P 500 | 0.966% | 7.616% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $13.00 price target on the stock.
Ratings data for VNDA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.82
30.10.25
30.10.25
€9.47
30.10.26
30.10.26
54.06%
24.04.26
24.04.26
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€5.25
01.08.24
01.08.24
€12.05
01.08.25
01.08.25
-31.81%
02.08.25
02.08.25